We encourage you to read and follow maps.org/safety for information regarding MAPS Code of Ethics for Psychedelic Psychotherapy and our practices to create a culture of safety in the psychedelic community.
You may safely and confidentially submit misconduct reports related to MAPS staff or collaborators to MAPS’ Compliance Team via email.
Participants in clinical trials can report concerns by contacting the study sponsor, found at clinicaltrials.gov, or the Institutional Review Board, found on your study materials.
All stakeholders at the Multidisciplinary Association for Psychedelic Studies (MAPS) are committed to cultivating a safe, ethical psychedelic community and psychedelic support system. We recognize that individuals have been harmed by misconduct in psychedelic-assisted therapy and support services, and we embrace our obligation to participate in creating norms and systems of accountability that respect the dignity and autonomy of people within this community.
In service of these commitments, we are continually examining, carefully developing, implementing, and adapting policies and practices to prevent, reasonably detect, and thoroughly respond to allegations of misconduct and safety concerns.
We hope that our work encourages others involved in the psychedelic community and psychedelic-assisted therapies to adopt similar commitments and participate actively in creating a culture of safety for psychedelic therapy. We invite you to review the carefully-considered practices outlined here and adapt them for your communities.
We encourage you to read and follow maps.org/safety for information regarding MAPS Code of Ethics for Psychedelic Psychotherapy and our practices to create a culture of safety in the psychedelic community.
You may safely and confidentially submit misconduct reports related to MAPS staff or collaborators to MAPS’ Compliance Team via email.
Participants in clinical trials can report concerns by contacting the study sponsor, found at clinicaltrials.gov, or the Institutional Review Board, found on your study materials.
Related content
- MAPS Code of Ethics for Psychedelic Psychotherapy
- Clinical Supervision in MDMA Therapy Training: An Ethical Commitment
- Creating an Ethical Framework for Psychedelic Therapy Research
- Ethical Considerations for Psychedelic Work with Women
We encourage you to read and follow maps.org/safety for information regarding MAPS Code of Ethics for Psychedelic Psychotherapy and our practices to create a culture of safety in the psychedelic community.
You may safely and confidentially submit misconduct reports related to MAPS staff or collaborators to MAPS’ Compliance Team via email.
Participants in clinical trials can report concerns by contacting the study sponsor, found at clinicaltrials.gov, or the Institutional Review Board, found on your study materials.
